跳至主要内容
临床试验/NCT02625077
NCT02625077撤回不适用

Valvuloplasty as Alternative to Toupet Fundoplication for the Minimal Invasive Treatment of Gastroesophageal Reflux Disease: A Randomized Controlled Trial

Meander Medical Center2 个研究点 分布在 1 个国家开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
Success rate, objective

研究概览

简要总结

This monocenter randomized controlled trial aims to compare postoperative outcomes of a laparoscopic valvuloplasty with a Toupet fundoplication in patients with GERD with a maximum hiatal hernia of 3cm. In addition, an economic evaluation of the new intervention will be done in order to determine cost-effectiveness and costs per quality-adjusted life-year (QALY).

详细描述

This is a prospective, interventional, double-blinded, monocenter randomized controlled trial comparing a laparoscopic gastroesophageal valvuloplasty to laparoscopic Toupet fundoplication in patients with proven GERD with a maximum hiatal hernia of 3cm. In this design, both patient and researcher are blinded to the treatment allocation.

Block randomization will be used to ensure an equal number in each treatment arm. Block randomization works by randomizing participants within blocks such that an equal number are assigned to each treatment. To reduce selection bias by predictability of the treatment allocation, random block sizes are used. Also the investigator is kept blind to the size of each block. A computer is used to generate 15 blocks for each participating center with random block sizes of 4, 8 and 12. Allocation proceeds by randomly selecting one of the orderings and assigning the next block of participants to study groups according to the specified sequence.

Patients will be included during a two-year period and followed for a minimum of one year. When a patient is referred to a participating surgeon for antireflux surgery, he or she will receive study information to give them sufficient time for consideration. The surgeon will ensure all required pre-operative diagnostic tests are performed and that the indication for surgery is valid. During a follow-up visit, the surgeon ascertains that the patient complies with all inclusion criteria and does not meet any of the exclusion criteria. Study participation will be discussed and after informed consent is obtained, the patient will be included in the trial.

After inclusion, the patient is immediately randomized but treatment allocation is not yet shared with the surgeon. The patient will receive validated questionnaires to record the pattern of symptoms, quality of life, medication and medical care usage. Data from the pre-operative tests will be recorded.

On the day of surgery, the surgeon will be able to see treatment allocation and after performing the appropriate surgical procedure, records the course and specifics of the surgical procedure. Patients will receive a diary to record their meals and symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Objectively proven GERD (by gastroscopy and/or 24-hour pH and/or impedance monitoring)
  • Written informed consent for study participation

排除标准

  • Hiatal hernia >3cm
  • Achalasia
  • Previous gastric surgery
  • Previous esophageal surgery
  • Inability to understand the Dutch language
  • Inability to understand and/or fill in the questionnaires

结局指标

主要结局

Success rate, objective

时间窗: 3 months post-operative

Defined as % of patients with normal values of reflux measured by pH and impedance monitoring

次要结局

  • Percent of patients with complaints of functional dysphagia according to the Rome III criteria(3 months post-operative, 1 year post-operative)
  • Complication rate(During surgery)
  • Cost-effectiveness(1 year post-operative)
  • Mortality rate(30 days)
  • Disease related reoperation rate(1 year)
  • Success rate, subjective(3 months post-operative, 1 year post-operative)
  • Conversion rate(During surgery)

研究者

发起方
Meander Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

R.C. Tolboom, MD

Project Leader

Meander Medical Center

研究点 (2)

Loading locations...

相似试验